Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases

Devkota HP 1 , Paudel KR 2 , Jha NK 3 , Gupta PK 4 , Singh SK 5 , Chellappan DK 6 Show all authors , Hansbro PM 2 , Dua K 7

Affiliations 

  • 1 Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chou-ku, Kumamoto City, Kumamoto, 862-0973, Japan
  • 2 School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia
  • 3 Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, Uttar Pradesh, 201310, India
  • 4 Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Greater Noida, 201310, Uttar Pradesh, India
  • 5 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India
  • 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia
  • 7 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia
Nanomedicine (Lond), 2021 11;16(27):2407-2410.
PMID: 34670398 DOI: 10.2217/nnm-2021-0275

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications